|
1
|
Tripathi D, Kant S, Pandey S#, Nasreen Z Ehtesham#, (2020), Resistin in Metabolism, Inflammation and Disease, The FEBS Journal, DOI: 10.1111/febs.15322; IF = 4.74, (ISSN: 1742-464X), # Corresponding Authors
|
|
2020
|
|
2
|
Pandey S, Yadav B, Pandey A, Tripathi T, Khawary M, Kant S, Tripathi D (2020); Lessons from SARS-CoV-2 Pandemic: Evolution, Disease Dynamics and Future, Biology; 9:141; DOI:10.3390/biology9060141, IF=3.79; (ISSN: 2079-7737)
|
|
2020
|
|
3
|
Gupta MN, Pandey S, Ehtesham NZ, Hasnain SE (2019), Medical Implications of Protein Moonlighting, Indian Journal of Medical Research; 149:322-325, DOI: 10.4103/ijmr.IJMR_2192_18, IF = 1.5, (ISSN: 0971-5916)
|
|
2019
|
|
4
|
Kumar A#, Alam A#, Grover S#, Pandey S#, Tripathi D, Kumari M, Rani M, Singh A, Akhter Y, Ehtesham NZ, Hasnain SE (2019), Peptidyl-prolyl isomerase-B is involved in Mycobacterium tuberculosis biofilm formation and a generic target for drug repurposing-based intervention. npj Biofilms and Microbiomes, 5:3, IF = 6.53 #equal first author; DOI:10.1038/s41522-018-0075-0; (ISSN No 2055-5008)
|
|
2019
|
|
5
|
Pandey S, Jha HC, Shukla SK, Shirley MK, Robertson ES, (2018) Epigenetic Regulation of Tumor Suppressors by Helicobacter pylori enhances EBV-induced proliferation of Gastric epithelial cells. mBio 9(2): e00649-18, DOI:10.1128/mBio.00649-18, IF = 6.9, (ISSN 2150-7511)
|
|
2018
|
|
6
|
Kumar A, Alam A, Tripathi D, Rani M, Khatoon H, Pandey S, Ehtesham NZ, Hasnain SE (2018). Protein adaptations in extremophiles: An insight into extremophilic connection of mycobacterial proteome, Seminars in Cell and Developmental Biology; 84:147–157 DOI: 10.1016/j.semcdb.2018.01.003, IF=6.1, (ISSN 1084-9521)
|
|
2018
|
|
7
|
Sharma A, Equbal MJ, Pandey S, Shaikh J, Ehtesham NZ, Hasnain SE, Chaudhuri TK, (2017), Immunodominant protein MIP_05962 from Mycobacterium indicus pranii displays chaperone activity; The FEBS Journal, 284(9):1338-1354, DOI: 10.1111/febs.14057; IF = 4.7, (ISSN 1742-464X)
|
|
2017
|
|
8
|
Pandey S, Tripathi D, Khubaib M, Kumar A, Shaikh J, Ehtesham NZ, Hasnain SE, (2017), Mycobacterium tuberculosis peptidyl-prolyl isomerases show immunogenicity, alter cytokine profile and aid in intracellular survival; Front. Cell. Infect. Microbiol. 7:38. DOI:10.3389/fcimb.2017.00038; IF = 3.5, (ISSN 2235-2988)
|
|
2017
|
|
9
|
Pandey S, Erle S Robertson (2017); Oncogenic Epstien-Barr Virus Recruits Nm23-H1 To Regulate Chromatin Modifiers, Laboratory Investigation, DOI: 10.1038/labinvest.2017.112, IF=4.2, (ISSN 0023-6837)
|
|
2017
|
|
10
|
Bhuwan M, Arora N, Sharma A, Khubaib M, Pandey S, Chaudhuri TK, Ehtesham NZ, Hasnain SE, (2016), Interaction of Mycobacterium tuberculosis virulence factor RipA with MoxR1, a chaperone, is required for transport through TAT secretion system, mBio,DOI:10.1128/mBio.02259-15; IF=6.9, (ISSN 2150-7511)
|
|
2016
|
|
11
|
Khubaib M#, Sheik JA#, Pandey S#, Shrikanth B, Bhuwan M, Khan N, Hasnain SE, Ehtesham NZ, (2016), Mycobacterium tuberculosis co-operonic PE32/PPE65 proteins alter host immune responses by hampering Th1 response, Frontiers in Microbiology, 7: 719 DOI: 10.3389/fmicb.2016.00719; IF=4.2, #Contributed as equal first author. (ISSN 1664-302X)
|
|
2016
|
|
12
|
Pandey S, Sharma A, Tripathi D, Kumar A, Khubaib M, Bhuwan M, Chaudhuri TK, Hasnain SE, Ehtesham NZ, (2016), Mycobacterium tuberculosis peptidyl-prolyl isomerases also exhibits chaperone like activity in vitro and in vivo; PLoS One, 11(3):e0150288. DOI:10.1371/journal.pone.0150288.IF = 2.8, (ISSN 1932-6203)
|
|
2016
|
|
13
|
Suragani M, Aadinarayana VD, Pinjari AB, Tanneeru K, Guruprasad L, Banerjee S, Pandey S, Chaudhuri TK, Ehtesham NZ, (2013), Human resistin, A proinflammatory cytokine, shows chaperone-like activity; Proc Natl Acad Sci USA.; 110(51):20467-72. DOI:10.1073/pnas.1306145110; IF=9.7, (ISSN 1091-6490)
|
|
2013
|